Nanotechnology-Abetted Astaxanthin Formulations in Multimodel Therapeutic and Biomedical Applications

Zohreh Jafari,Ashkan Bigham,Sahar Sadeghi,Sayed Mehdi Dehdashti,Navid Rabiee,Alireza Abedivash,Mojtaba Bagherzadeh,Behzad Nasseri,Hassan Karimi-Maleh,Esmaeel Sharifi,Rajender S. Varma,Pooyan Makvandi
DOI: https://doi.org/10.1021/acs.jmedchem.1c01144
IF: 8.039
2021-01-01
Journal of Medicinal Chemistry
Abstract:Astaxanthin (AXT) is one of the most important fat-soluble carotenoids that have abundant and diverse therapeutic applications namely in liver disease, cardiovascular disease, cancer treatment, protection of the nervous system, protection of the skin and eyes against UV radiation, and boosting the immune system. However, due to its intrinsic reactivity, it is chemically unstable, and therefore, the design and production processes for this compound need to be precisely formulated. Nanoencapsulation is widely applied to protect AXT against degradation during digestion and storage, thus improving its physicochemical properties and therapeutic effects. Nanocarriers are delivery systems with many advantages—ease of surface modification, biocompatibility, and targeted drug delivery and release. This review discusses the technological advancement in nanocarriers for the delivery of AXT through the brain, eyes, and skin, with emphasis on the benefits, limitations, and efficiency in practice.
What problem does this paper attempt to address?